What is SkyCell?
Founded in 2012 and headquartered in Zug, Switzerland, SkyCell specializes in the production of advanced medical containers designed to ensure the integrity and safety of pharmaceutical shipments. The company's innovative solutions address critical supply chain challenges within the life sciences sector, positioning it as a key player in the specialized field of cold chain logistics for sensitive medical products. The recent major strategic investment signals strong market confidence in SkyCell's technology and business model.
How much funding has SkyCell raised?
SkyCell has raised a total of $269.8M across 4 funding rounds:
Other Financing Round
$62M
Series C
$34.8M
Other Financing Round
$57M
Series D
$116M
Other Financing Round (2020): $62M with participation from BCGE Bank, Swiss Entrepreneurs Fund, and MVM Partners
Series C (2021): $34.8M, investors not publicly disclosed
Other Financing Round (2023): $57M supported by Catalyst
Series D (2024): $116M featuring Tybourne Capital Management, Commonwealth Cyber Initiative, and Catalyst Investors
Key Investors in SkyCell
Tybourne Capital Management
Tybourne Capital Management is an investment advisory firm that offers a variety of investment-related services to clients, likely focusing on growth-stage companies.
Commonwealth Cyber Initiative
The Commonwealth Cyber Initiative (CCI) is Virginia's primary hub for cybersecurity research, innovation, and workforce development, connecting researchers with funding and collaboration opportunities.
Catalyst Investors
Catalyst Investors is a growth equity firm specializing in actively helping B2B companies scale their operations and achieve their full potential through strategic, tactical, and financial support.
What's next for SkyCell?
With a substantial total funding amount of $269.8M and a recent strategic investment of $116M, SkyCell is poised for accelerated growth and market expansion. This significant capital backing is expected to fuel further innovation in its container technology, enhance its manufacturing capabilities, and broaden its global reach. The company's trajectory suggests a focus on scaling operations to meet the increasing demand for reliable and secure pharmaceutical logistics solutions, likely targeting further enterprise partnerships and market penetration.
See full SkyCell company page
